Skip to main content
Premium Trial:

Request an Annual Quote

Human Genome Sciences Opens Genomics Drug Plant

Premium

ROCKVILLE, Md.--Human Genome Sciences opened a $42 million plant here this month, where it said it will manufacture drugs resulting from genomics research and development. Calling his company the "world's genomics pioneer," William Haseltine, CEO of Human Genome Sciences, said, "HGS was the first group anywhere to sequence most of the genes in the human genome. HGS was also the first company to place three genomics-derived drugs into human clinical trials." He added, "Our hope is that HGS will be the first company to manufacture and market genomics-derived drugs."

The plant is situated on Johns Hopkins University's Belward Research Campus, a 138-acre tract to be developed by the university to focus on research and development laboratories, associated office space, government agencies, and healthcare delivery facilities. Construction by Human Genome Sciences is already underway on a 40,000-square-foot expansion shell to house an additional production line adjacent to the new 80,000-square-foot manufacturing and process development plant.

Filed under

The Scan

Gone, But Now Reconstructed SARS-CoV-2 Genomes

In a preprint, a researcher describes his recovery of viral sequences that had been removed from a common database.

Rare Heart Inflammation Warning

The Food and Drug Administration is adding a warning about links between a rare inflammatory heart condition and two SARS-CoV-2 vaccines, Reuters reports.

Sandwich Sampling

The New York Times sent tuna sandwiches for PCR analysis.

Nature Papers Describe Gut Viruses, New Format for Storing Quantitative Genomic Data, More

In Nature this week: catalog of DNA viruses of the human gut microbiome, new dense depth data dump format to store quantitative genomic data, and more.